FierceBiotech 2026-02-09 Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
Illumina 2026-02-09 This Week in Chancery Court: Trump Media SPAC Appeal, Illumina - Bloomberg Law News
10x Genomics Blog 2026-02-09 10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN
FierceBiotech 2026-02-09 CSL signs on to $328M research collab with option for Memo’s immunoglobulin antibody tech
FierceBiotech 2026-02-09 The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
eLife 2026-02-09 Mouse skeletal muscle satellite cells co-opt the tenogenic gene Scleraxis to instruct regeneration
Illumina 2026-02-08 Illumina Crash 10% on Earnings: Why the Stock Could Rebound to $185 in 2026 - TIKR.com
10x Genomics Blog 2026-02-08 10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
10x Genomics Blog 2026-02-08 Is 10x Genomics (TXG) Using PharosAI’s NHS Partnership To Quietly Recast Its Spatial Biology Moat? - simplywall.st
Illumina 2026-02-08 Is Illumina’s (ILMN) Clinical Consumables Surge Quietly Redefining Its Core Investment Story? - Yahoo Finance UK
Illumina 2026-02-08 Assessing Illumina (ILMN) Valuation After Recent Share Price Weakness And Mixed Long Term Returns - simplywall.st
Lonza News 2026-02-08 Lonza’s Strategic Pivot Fuels Robust Growth and Shareholder Returns - AD HOC NEWS
Endpoints News 2026-02-07 #ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS